Sugar micro needles as transdermic drug delivery system

Area of Science:

• Biomaterials Science
• Dermatology
• Pharmaceutical Sciences

Background:

• Transdermal drug delivery offers a minimally invasive alternative to traditional administration routes.
• Developing safe and effective transdermal systems remains a challenge, particularly for controlled drug release.
• Biodegradable materials present an opportunity for novel drug delivery vehicles.

Purpose of the Study:

• To design and fabricate sugar microneedles for transdermal drug delivery.
• To evaluate the biocompatibility and efficacy of these microneedles in a clinical setting.
• To assess the potential of sugar microneedles as a novel drug delivery system.

Main Methods:

• Fabrication of maltose-based microneedles with lengths from 150 micrometers to 2 millimeters.
• Incorporation of pharmaceutical agents, such as ascorbate-2-glycoside, into the microneedle matrix.
• Clinical testing on 10 healthy volunteers, involving insertion of 500 microneedles into forearm skin.
• Monitoring for dermatological reactions using International Contact Dermatitis Research Group criteria.

Main Results:

• Sugar microneedles were successfully fabricated and demonstrated spontaneous dissolution via hydrolysis in the skin.
• Microneedles containing 5 wt% ascorbate-2-glycoside released the active compound into the epidermis and dermis.
• No adverse dermatological effects were observed in any of the volunteers during the study.
• The microneedle system showed basic tolerance to healthy human skin.

Conclusions:

• Biodegradable sugar microneedles represent a promising novel approach for transdermal drug delivery.
• The fabricated microneedles are safe for skin application and facilitate drug release within the skin layers.
• This technology holds potential for future development in minimally invasive drug administration.